This article was originally published in RAJ Devices
Two jailed in US following sales of unapproved sterilisation devices
You may also be interested in...
This month’s column covers deals announced between 1-23 April 2020.
The new US public benefit pharma manufacturing firm Phlow has received significant federal funding in a bid to improve domestic supply security. Scrip speaks to prominent executives in India's industry over whether this model, if widely replicated, could put at risk the clout and market access plans of the Indian generic industry, a major supplier to the US market.
GSK will appeal a finding that it doesn’t support its “100% Natural” claim for Benefiber Original and Healthy Shape. Question asked in the review from a P&G challenge reflects FDA’s ongoing consideration of whether a public health concern will emerge if it doesn’t substantially expand its regulation of use of the term.